(Q47371550)

15 January 2018

title

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C*. (English)

1 reference

15 January 2018

0 references

1 reference

1 reference

1 reference

M S Seyam

1

1 reference

15 January 2018

D A Freshwater

series ordinal

2

1 reference

15 January 2018

K O'Donnell

series ordinal

3

1 reference

15 January 2018

D J Mutimer

series ordinal

4

1 reference

15 January 2018

publication date

1 September 2005

1 reference

15 January 2018

Journal of Viral Hepatitis

published in

1 reference

15 January 2018

volume

12

1 reference

15 January 2018

issue

5

1 reference

15 January 2018

page(s)

531-535

1 reference

15 January 2018

Side effects of therapy of hepatitis C and their management

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

The intricate interface between immune system and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Hepatitis C and the leptin system: bound leptin levels are elevated in patients with hepatitis C and decrease during antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Ghrelin enhances appetite and increases food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00637.X

10.1111/J.1365-2893.2005.00637.X

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018